FDA.reportPublic FDA data

Juluca 50 MG / 25 MG Oral Tablet

RxCUI
1989506
RxNorm name
Juluca 50 MG / 25 MG Oral Tablet
Display name
Juluca 50 MG / 25 MG Oral Tablet
Full name
Juluca 50 MG / 25 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JulucaDOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDEViiV Healthcare Company806653d1-bf35-4924-b999-ad5d21821cc12025-10-29Warnings, Adverse reactionsExact identifier
rxcui: 1989506

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
806653d1-bf35-4924-b999-ad5d21821cc1Juluca 50 MG / 25 MG Oral Tablet [PSN] · dolutegravir 50 MG / rilpivirine 25 MG Oral Tablet [Juluca] [SBD] · Juluca (dolutegravir 50 mg (equivalent to 52.6 mg dolutegravir sodium) / rilpivirine 25 mg (equivalent to 27.5 mg rilpivirine HCl)) Oral Tablet [SY]315These highlights do not include all the information needed to use JULUCA safely and effectively. See full prescribing information for JULUCA. JULUCA (dolutegravir and rilpivirine tablets), for oral use Initial U.S. Approval: 201720251029